Apolipoprotein E4 genotype in combination with poor metabolic profile is associated with reduced cognitive performance in healthy postmenopausal women: implications for late onset Alzheimer's disease. Issue 1 (January 2019)
- Record Type:
- Journal Article
- Title:
- Apolipoprotein E4 genotype in combination with poor metabolic profile is associated with reduced cognitive performance in healthy postmenopausal women: implications for late onset Alzheimer's disease. Issue 1 (January 2019)
- Main Title:
- Apolipoprotein E4 genotype in combination with poor metabolic profile is associated with reduced cognitive performance in healthy postmenopausal women
- Authors:
- Karim, Roksana
Koc, Melissa
Rettberg, Jamaica R.
Hodis, Howard N.
Henderson, Victor W.
St. John, Jan A.
Allayee, Hooman
Brinton, Roberta D.
Mack, Wendy J. - Abstract:
- Abstract: Objective: We hypothesized the association of metabolic profile on cognition in postmenopausal women will be greater among ApoE4 carriers compared with noncarriers. Methods: Metabolic biomarkers and measures of global cognition, executive functions, and verbal memory, collected among postmenopausal females, were used in this analysis. Clustering analyses of metabolic biomarkers revealed three phenotypes: healthy, predominantly hypertensive, and poor metabolic with (borderline normal laboratory values). General linear models tested whether an association of metabolic cluster with cognition differed by ApoE4 genotype. Results: In the total sample of 497 women, verbal memory was lower in the poor metabolic cluster ( P = 0.04). Among ApoE4+ women, performance in all cognitive domains was lowest in the poor metabolic cluster. Differences in executive functions among metabolic clusters were detected only in ApoE4+ women ( P value for interaction = 0.003). Conclusions: In a general population of postmenopausal women, association between poor metabolic profile with reduction in cognitive performance is more apparent in women who carry an ApoE4 allele. These data indicate a window of opportunity for interventions to reverse the trajectory of the preclinical phase of Alzheimer's disease. Abstract : Supplemental Digital Content is available in the text
- Is Part Of:
- Menopause. Volume 26:Issue 1(2019)
- Journal:
- Menopause
- Issue:
- Volume 26:Issue 1(2019)
- Issue Display:
- Volume 26, Issue 1 (2019)
- Year:
- 2019
- Volume:
- 26
- Issue:
- 1
- Issue Sort Value:
- 2019-0026-0001-0000
- Page Start:
- Page End:
- Publication Date:
- 2019-01
- Subjects:
- Alzheimer disease -- Biomarker -- Cognitive impairment -- Menopause -- Metabolic profile
Menopause -- Periodicals
618.175005 - Journal URLs:
- http://journals.lww.com/menopausejournal/pages/default.aspx ↗
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=toc&D=yrovft&AN=00042192-000000000-00000 ↗
http://www.menopausejournal.com/ ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/GME.0000000000001160 ↗
- Languages:
- English
- ISSNs:
- 1072-3714
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5678.457030
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 11297.xml